Company · CIK 0001438533
Travere Therapeutics, Inc.
TVTXSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$52.13+$0.08 (+0.163%)
TVTX · Last trade
- Prev close
- $52.04
- Range (29d)
- $52.04 – $67.51
On the record
Recent filings
- 8-KTVTXCurrent report0001438533-26-000068 · 505.6 KBSEC(opens sec.gov)
- 144TVTXTravere Therapeutics, Inc.0001950047-26-009642 · 6.5 KBSEC(opens sec.gov)
- 144TVTXTravere Therapeutics, Inc.0001950047-26-009625 · 6.4 KBSEC(opens sec.gov)
- 144TVTXTravere Therapeutics, Inc.0001950047-26-009577 · 5.7 KBSEC(opens sec.gov)
- 144TVTXTravere Therapeutics, Inc.0001950047-26-009576 · 5.7 KBSEC(opens sec.gov)
- 144TVTXTravere Therapeutics, Inc.0001950047-26-009566 · 5.7 KBSEC(opens sec.gov)
- 144TVTXTravere Therapeutics, Inc.0001950047-26-009523 · 5.0 KBSEC(opens sec.gov)
- 144TVTXTravere Therapeutics, Inc.0001950047-26-009521 · 6.5 KBSEC(opens sec.gov)
- 144TVTXTravere Therapeutics, Inc.0001950047-26-009520 · 5.6 KBSEC(opens sec.gov)
- 144TVTXTravere Therapeutics, Inc.0001950047-26-009513 · 5.0 KBSEC(opens sec.gov)
Insiders
- ASELAGE STEVEDirector
- Baynes Roy D.Director
- Broadfin Capital, LLC10% Owner
- Broadfin Healthcare Master Fund Ltd10% Owner
- Bruhn Suzanne LouiseDirector
- Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
- Clague LauraChief Financial Officer
- Cline Christopher R.CHIEF FINANCIAL OFFICER
- Coughlin TimothyDirector
- Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
Tickers
Addresses
business
3611 VALLEY CENTRE DR SUITE 300
SAN DIEGO, CA, 92130
mailing
3611 VALLEY CENTRE DR SUITE 300
SAN DIEGO, CA, 92130
Former names
- Retrophin, Inc.2020-11-13
- Desert Gateway, Inc.2013-02-19
Same industry